<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336568">
  <stage>Registered</stage>
  <submitdate>20/02/2011</submitdate>
  <approvaldate>21/05/2012</approvaldate>
  <actrnumber>ACTRN12612000531819</actrnumber>
  <trial_identification>
    <studytitle>Paracetamol  Rectal Suppository for  postoperative pain reduction in Abdominal Hysterectomy A Randomized controlled trial</studytitle>
    <scientifictitle>Paracetamol  Rectal Suppository for  postoperative pain reduction in Abdominal Hysterectomy A Randomized controlled trial</scientifictitle>
    <utrn>U1111-1119-5401</utrn>
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>healthy woman and no underlying disease</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arm1: paracetamol rectal suppositories 40 mg/kg single dose 
   (1 tab = 325 mg) immediately postoperation.</interventions>
    <comparator>Arm2: placebo made from fat soluble parafin identical in appearance with paracetamol rectal suppository, single dose, immediately postoperation</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>postoperative pain in abdominal hysterectomy using questionnaires and visual analog scale (VAS)</outcome>
      <timepoint>at 6 months after randomization</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Adverse effects such as nausea vomiting, fever using questionnaire</outcome>
      <timepoint>at 6 months after randomization</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Opioids consumption using medical records</outcome>
      <timepoint>at 6 months after randomization</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Elective benign abdominal hysterectomy
Age &lt;70 years
Body weight 30-80 kg</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>paracetamol hypersensitivity
Bleeding disorders
Had underlying diseases
Renal, hepatic dysfunction</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes were used</concealment>
    <sequence>computer generated the sequence number</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>None</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/10/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Thailand</country>
      <state>Khon Kaen</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Khon Kaen Hospital</primarysponsorname>
    <primarysponsoraddress>Srichan Road
Muang
Khon Kaen
40000</primarysponsoraddress>
    <primarysponsorcountry>Thailand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Khon Kaen Hospital</fundingname>
      <fundingaddress>Srichan Road
Muang
Khon Kaen
40000</fundingaddress>
      <fundingcountry>Thailand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Tanyalak Wongluecha</sponsorname>
      <sponsoraddress>Srichan Road
Muang
Khon Kaen
40000</sponsoraddress>
      <sponsorcountry>Thailand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Paracetamol in conjunction with strong opioids such as morphine shown to reduce the amount of opioid used and improve analgesic effect. Paracetamol has many available forms such as oral injection and suppository. In the first 24 hours after surgery, women were not allowed to have any ingestion, except intravenous solution. Therefore, paracetamol rectal suppository was add with strong opioids (morphine or pethidine) routinely postoperative painkillers for postoperative pain relief. The aims of adding paracetamol rectal suppository were to reduce opioids consumption and avoid their adverse effects, e.g. nausea and/or vomiting, orthostatic hypotension and respiratory compression. We therefore would like to study the effectiveness and safety of paracetamol rectal suppository in pain reduction in women undergoing total abdominal hysterectomy. We hypothesized that paracetamol rectal suppository can reduce postoperative pain in abdominal hysterectomy more effective than placebo. The primary outcome was postoperative pain score and the secondary outcome was volume of opioids consumption.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Khon Kaen Hospital Ethics Committee</ethicname>
      <ethicaddress>Srichan Road
Muang
Khon Kaen
40000</ethicaddress>
      <ethicapprovaldate>19/08/2010</ethicapprovaldate>
      <hrec>78/01/2553</hrec>
      <ethicsubmitdate>1/08/2010</ethicsubmitdate>
      <ethiccountry>Thailand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Naroemit Wonglikitpunya</name>
      <address>Khon Kaen Hospital 
Srichan Road
Muang
Khon Kaen
40000</address>
      <phone>+6643336789 ext 3736</phone>
      <fax>+6643336789 ext 3736</fax>
      <email>Tanyalak_54@hotmail.com</email>
      <country>Thailand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Tanyalak Wongluecha</name>
      <address>Khon Kaen Hospital 
Srichan Road
Muang
Khon Kaen
40000</address>
      <phone>+6643336789 ext 3736</phone>
      <fax>+6643336789 ext 3736</fax>
      <email>Tanyalak_54@hotmail.com</email>
      <country>Thailand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>